Trial Profile
A Randomized Phase I Trial of Nanoparticle Albumin Bound Paclitaxel (Nab-paclitaxel, Abraxane) With or Without Mifepristone for Advanced Breast Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Mifepristone (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer; Male breast cancer
- Focus Adverse reactions
- 10 Sep 2018 Status changed from active, no longer recruiting to completed.
- 08 Sep 2017 Planned End Date changed from 1 Nov 2017 to 1 Nov 2018.
- 08 Sep 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.